Literature DB >> 28288256

Review of the Drug Trials Snapshots Program of the US Food and Drug Administration: Women in Cardiovascular Drug Trials.

John Whyte1, Janet Woodcock2, Junyang Wang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28288256      PMCID： PMC5470354          DOI： 10.1001/jamainternmed.2017.0033

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

1.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

2.  Demographics of clinical trials participants in pivotal clinical trials for new molecular entity drugs and biologics approved by FDA From 2010 to 2012.

Authors:  Noha Eshera; Hawi Itana; Lei Zhang; Greg Soon; Emmanuel O Fadiran
Journal:  Am J Ther       Date:  2015 Nov-Dec       Impact factor: 2.688

3.  Prevalence of clinical venous thromboembolism in the USA: current trends and future projections.

Authors:  S B Deitelzweig; B H Johnson; J Lin; K L Schulman
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

4.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

5.  Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

Authors:  David B Badesch; Gary E Raskob; C Greg Elliott; Abby M Krichman; Harrison W Farber; Adaani E Frost; Robyn J Barst; Raymond L Benza; Theodore G Liou; Michelle Turner; Scott Giles; Kathy Feldkircher; Dave P Miller; Michael D McGoon
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

6.  Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry.

Authors:  Leslee J Shaw; Richard E Shaw; C Noel Bairey Merz; Ralph G Brindis; Lloyd W Klein; Brahmajee Nallamothu; Pamela S Douglas; Ronald J Krone; Charles R McKay; Peter C Block; Kathleen Hewitt; William S Weintraub; Eric D Peterson
Journal:  Circulation       Date:  2008-03-31       Impact factor: 29.690
  6 in total
  4 in total

1.  Working Together to Address Women's Health in Research and Drug Development: Summary of the 2017 Women's Health Congress Preconference Symposium.

Authors:  Irwin M Feuerstein; Marjorie R Jenkins; Susan G Kornstein; Michael S Lauer; Pamela E Scott; Tonse N K Raju; Tamara Johnson; Stephanie Devaney; Milena Lolic; Marsha Henderson; Janine Austin Clayton
Journal:  J Womens Health (Larchmt)       Date:  2018-10       Impact factor: 2.681

2.  Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017.

Authors:  Anuradha Ramamoorthy; Todd C Knepper; Christine Merenda; Martin Mendoza; Howard L McLeod; Jonca Bull; Lei Zhang; Michael Pacanowski
Journal:  Clin Pharmacol Ther       Date:  2018-09-14       Impact factor: 6.875

3.  Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.

Authors:  Muhammad Shahzeb Khan; Izza Shahid; Tariq Jamal Siddiqi; Safi U Khan; Haider J Warraich; Stephen J Greene; Javed Butler; Erin D Michos
Journal:  J Am Heart Assoc       Date:  2020-05-19       Impact factor: 5.501

Review 4.  Disparities in Cardiovascular Care and Outcomes for Women From Racial/Ethnic Minority Backgrounds.

Authors:  Sujana Balla; Sofia Elena Gomez; Fatima Rodriguez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.